Patents for A61P 17 - Drugs for dermatological disorders (106,455)
04/2006
04/20/2006US20060084809 Compounds as PDE IV and TNF-inhibitors
04/20/2006US20060084685 Ophthalmological use of roflumilast for the treatment of diseases of the eye
04/20/2006US20060084684 Topically applicable pharmaceutical preparation
04/20/2006US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
04/20/2006US20060084661 IL-8 receptor antagonists
04/20/2006US20060084653 Beta-sheet mimetics and composition and methods relating thereto
04/20/2006US20060084641 IL-8 receptor antagonists
04/20/2006US20060084143 Screen for agonists and antagonists; treat solid tumors, vascular deficiencies; polypeptide, polynucleotide, plasmid; chemotherapeutic agents, alkylating agents, antimetabolites, vinca alkaloids, plant extracts, nitrosoureas, topoisomerase inhibitors, platinum analogs, adrenocortical suppressants
04/20/2006US20060084121 OX2 receptor homologs
04/20/2006US20060083796 Orally administrable composition for improving hair and coat quality
04/20/2006US20060083792 Utilizing nanocrystalline silver metal, alloy or compound for localized tissue infections; reducing side effects; limiting overuse of antibiotics
04/20/2006US20060083754 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases
04/20/2006US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies
04/20/2006DE202006000004U1 Topical composition used to relieve e.g. psoriasis, comprises trichloroethylene and partial glyceride of natural fatty acid, cetyl alcohol, white vaseline, Hamamelis extract, antiseptic, silicone and auxiliary-, carrier- and odor materials
04/20/2006DE102005000868A1 Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren Compositions with inhibitors of prostaglandin and / or leukotriene synthesis in combination with stimulators of the release of cutaneous neuromediators
04/20/2006CA2584293A1 Crig polypeptide for prevention and treatment of complement-associated disorders
04/20/2006CA2584261A1 Pharmaceutical composition
04/20/2006CA2584169A1 Remedies/preventives for chronic skin disease
04/20/2006CA2583846A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrates thereof, and intermediates in the production thereof
04/19/2006EP1647278A1 Use of legume products for the treatment and prevention of radiotherapy-induced skin damage
04/19/2006EP1647274A1 Remedy for pruritus comprising piperidine derivative as the active ingredient
04/19/2006EP1646656A2 Human antibody molecules for il-13
04/19/2006EP1646651A2 Novel peptidic conjugates for alopecia preventive and curative treatment
04/19/2006EP1646382A2 Compounds, compositions and methods
04/19/2006EP1646359A1 Preparation for topical use with the function of combating hair loss
04/19/2006EP1556140A4 Novel compounds
04/19/2006EP1537112B1 Condensed pyridines and pyrimidines with tie2 (tek) activity
04/19/2006EP1474122A4 Compounds for blocking androgen receptors
04/19/2006EP1448564B1 Substituted indolizine-like compounds and methods of use
04/19/2006EP1387838B1 Cyanoanthranilamide derivatives and the use thereof as medicaments
04/19/2006EP1317428B1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors
04/19/2006EP1296692B1 Use of a formulation made of or containing at least one dissimilated milk serum
04/19/2006EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents
04/19/2006EP1227820B1 Oligosaccharide aldonic acids and their topical use
04/19/2006EP1212330B1 Androgen receptor modulator compounds and methods
04/19/2006EP1003479B1 Method and compositions for treating late phase allergic reactions and inflammatory diseases
04/19/2006CN1761686A Proteoglycan isolated from cartilaginous fish and process for producing the same
04/19/2006CN1761664A Immunomodulating heterocyclic compounds
04/19/2006CN1761662A Composition for promoting production of type I collagen and/or elastin
04/19/2006CN1761649A Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2
04/19/2006CN1761470A Combination of a macrolide t-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease
04/19/2006CN1761466A Therapeutic and/or preventive agent for chronic skin disease
04/19/2006CN1759879A Ointment of Chinese traditional medicine for treating bedsore, and preparation method
04/19/2006CN1759862A Prescription of arenobufagin drop pills and preparation method
04/19/2006CN1759841A Preparation of bio-membrane in use for promoting wound healing, and preparation method
04/19/2006CN1252070C Urea substituted imidazoquinolines
04/19/2006CN1252069C 2-aryl-naphthyridin-4-ones as antitumor agent
04/19/2006CN1252065C Cinnoline compounds
04/19/2006CN1252040C Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
04/19/2006CN1251754C Composite medicine for baldness
04/19/2006CN1251750C Health care fluid for nursing skin
04/19/2006CN1251747C Medicine for treating burns, scalds, other multiple skin disease and traumatic injury
04/19/2006CN1251746C Ointment for curing burn
04/19/2006CN1251738C Chinese medicine for treating ashen nail and its preparation method
04/19/2006CN1251736C Chinese medicinal infusion for treating shingles, parotitis acute mamitis and its manufacturing method
04/19/2006CN1251730C Production technology of medicine for treating burn
04/19/2006CN1251724C Alopecia treating traditional Chinese medicine preparation and its preparation process
04/19/2006CN1251711C External use anti-inflammatory and myogenic medicine of chinese medicine and its preparing method
04/19/2006CN1251708C Traditional Chinese herb medicine plaster for treating bone injury, and its prepn. method
04/19/2006CN1251694C Chinese medicine formulation for treating upper respiratory system disease, skin infection and haemorr hoids and its preparing method
04/19/2006CN1251676C Phenyl xanthine derivative
04/19/2006CN1251674C Medicinal compsn. for treating skin disease and preparation technique
04/19/2006CN1251669C Acne removing and skin rejuvenating cream
04/18/2006US7030265 Retinol derivatives, the method of preparations and the uses thereof
04/18/2006US7030246 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof
04/18/2006US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment
04/18/2006US7030218 Extending ligation technique to peptides, polypeptides, other polymers and other molecules via an amide bond; used in the synthesis of optionally polymer-modified, synthetic bioactive proteins, and of pharmaceutical compositions
04/18/2006US7030160 An agonist as beta-3 adrenergic receptors; chemical intermediates preparing through decyclization, hydroxylation; for treating gastrointestinal diseases, obesity, diabetics, psychotropic agents, nervous system disorders
04/18/2006US7030153 Including methylsulfonyl attachment, treating arthritis, with analgesic activity without erosion of the stomach, side effect reduction
04/18/2006US7030129 Method of reducing and treating UVB-induced immunosuppression
04/18/2006US7030123 Indole derivatives with vascular damaging activity
04/18/2006US7030090 Immune-modulating peptide
04/18/2006US7030086 Stabilized liquid polypeptide-containing pharmaceutical compositions
04/18/2006US7029914 DNA encoding SNORF36 receptors
04/18/2006US7029894 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
04/18/2006US7029877 binding protease thrombin to phosphoethanolamine binding protein
04/18/2006US7029713 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same
04/18/2006US7029706 Composition for the treatment of cutaneous mycosis
04/18/2006US7029704 hydrogen peroxide, sodium bicarbonate and apple cider vinegar applied to feet to prevent athlete's foot
04/18/2006US7029688 Methods and compositions to prevent formation of adhesions in biological tissues
04/18/2006US7029665 Human suppressor tRNA oligonucleotides and methods for use for same
04/18/2006CA2302819C Use of a substance agonist of a receptor associated with a chlorine or potassium canal for treating sensitive skins
04/18/2006CA2296984C Composition for topical application to the skin and/or skin appendages, comprising at least one compound containing a phenyloxime fragment
04/13/2006WO2006039014A1 Cosmetic neurotoxin compositions comprising a botulinum toxin component and methods
04/13/2006WO2006038721A1 External preparation
04/13/2006WO2006038680A1 2-arylcarboxamide-nitrogeneous heterocycle compound
04/13/2006WO2006037604A1 Novel antibodies directed to the mammalian eag1 ion channel protein
04/13/2006WO2006037188A1 Compositions and methods for inducing melanogenesis in a subject
04/13/2006WO2006024770A3 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof
04/13/2006WO2006018185A3 Dihydropteridinones for the treatment of cancer diseases
04/13/2006WO2005117897A3 Hepoxilins and modulators of ichthyin for treatment skin disorders
04/13/2006US20060079713 Novel salt forms of poorly soluble probucol esters and ethers
04/13/2006US20060079670 98 human secreted proteins
04/13/2006US20060079563 Cyclic protein tyrosine kinase inhibitors
04/13/2006US20060079548 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
04/13/2006US20060079525 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis
04/13/2006US20060079503 Thiazolidinones and the use therof as polo-like kinase inhibitors
04/13/2006US20060079489 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
04/13/2006US20060079451 Heparin-binding proteins modified with sugar chains, method of producing the same and pharmaceutical compositions containing same
04/13/2006US20060078989 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use